• Facebook
  • YouTube
PNG transparent image_(1).png

Educate ~ Advocate ~ Collaborate

  • Home

  • Symposium

    • 2020 VET Virtual Conference
    • 2020 Speakers
    • 2020 Handouts; Access for Attendees Only
    • Past Symposiums
    • 2020 Symposium Presentations
  • Get Involved

    • Become A Member
    • Renew Your Membership
  • FAQ

  • Vet Members

    • Regulatory Updates
    • Open Library
    • Product List (OCS)
    • Chat Room
    • Research Library
    • Talking To Your Clients
    • Harm Reduction Education
    • Learning Modules
    • Newsletter Archives
    • In-Clinic Posters
  • For Pet Families

  • Find A Veterinarian

  • Cannabis Blog

  • More

    Use tab to navigate through the menu items.
    • facebook

    OPHTHALMOLOGY

    Effects of a topically applied 2% delta-9- tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs

    ​

    Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study. - PubMed - NCBI

     

    Cannabinoids: a novel treatment for glaucoma - SAMUDRE - 2014 - Acta Ophthalmologica - Wiley Online Library

     

    Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease

     

    Corneal endothelial changes in long-term cannabinoid users: Cutaneous and Ocular Toxicology: Vol 37, No 1

     

    Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation

     

    The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation

    ©2018 by Canadian Association of Veterinary Cannabinoid Medicine. Proudly created with Wix.com